Non-ribosomal peptide synthetase cysteine adenylation domain (NRPS Cys-A domain) (NRPS Cys-A domain)

The Non-ribosomal peptide synthetase (NRPS) cysteine adenylation domain is a specialized enzymatic unit within modular NRPS complexes that catalyzes the first step in the incorporation of L-cysteine into bioactive peptides. This domain functions by recognizing L-cysteine and activating it with ATP to form a highly reactive cysteinyl-adenylate intermediate, which is then transferred to a thiolation domain for further assembly (Duckworth et al., 2012). In many pathogenic bacteria, this specific domain is essential for the biosynthesis of siderophores—iron-chelating molecules like yersiniabactin and acinetobactin—that allow the pathogen to acquire iron from the host environment (Ferreras et al., 2005). Because iron acquisition is a fundamental requirement for bacterial virulence and survival during infection, the cysteine adenylation domain is a high-priority target for the development of anti-virulence therapeutics. Inhibitors such as 5'-O-(N-L-cysteinylsulfamoyl)adenosine (Cys-AMS) have been developed to mimic the transition state of the adenylation reaction, effectively blocking the enzyme and reducing the pathogenicity of organisms like Yersinia pestis and Acinetobacter baumannii (Neres et al., 2008). While these inhibitors show high potency and selectivity, a primary therapeutic challenge involves ensuring they do not cross-react with human aminoacyl-tRNA synthetases, which share a similar structural fold and catalytic mechanism (Miethke & Marahiel, 2007).

Other names

Cysteine-activating adenylation domainCysteine-specific adenylation domainNRPS A-domainAmino acid activating domain

Competitive inhibition of the adenylation reaction by mimicking the aminoacyl-adenylate intermediate, thereby blocking the activation of L-cysteine and halting the assembly of non-ribosomal peptides.